Published in Int Ophthalmol on October 09, 2015
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet (2006) 8.33
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med (2007) 5.41
Reiter's disease and HL-A 27. Lancet (1973) 4.10
The natural history of uveitis. Int Ophthalmol (1990) 3.28
The HLA system. Second of two parts. N Engl J Med (2000) 2.80
Acute anterior uveitis and HL-A 27. Lancet (1973) 2.74
Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol (1982) 2.61
Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol (1982) 2.51
The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol (1996) 2.47
Control of the complement system. Adv Immunol (1996) 2.43
Acute anterior uveitis and HLA-B27. Surv Ophthalmol (2005) 2.42
Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev (2003) 2.12
Histopathology of birdshot retinochoroidopathy. Br J Ophthalmol (2002) 1.88
Birdshot chorioretinopathy. Surv Ophthalmol (2005) 1.87
Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70
The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol (2007) 1.37
Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol (2002) 1.33
Intraoperative SD-OCT in macular surgery. Ophthalmic Surg Lasers Imaging (2013) 1.25
Immune mechanisms in uveitis. Springer Semin Immunopathol (1999) 1.23
Pars planitis: clinical features and class II HLA associations. Ophthalmology (1999) 1.22
Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10. Immunology (2011) 1.19
Overview of safety of non-biologic and biologic DMARDs. Rheumatology (Oxford) (2012) 1.16
Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol (2000) 1.15
IL-10 genotype analysis in patients with Behçet's disease. Hum Immunol (2006) 1.15
Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2001) 1.14
Acute anterior uveitis and HLA-B27. Surv Ophthalmol (1992) 1.08
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci (1994) 1.08
Complement factor H related proteins in immune diseases. Vaccine (2008) 1.07
Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefes Arch Clin Exp Ophthalmol (2003) 1.04
Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.04
Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol (2006) 1.00
The association of HLA class II with pars planitis. Am J Ophthalmol (2001) 0.94
Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population. Mol Vis (2010) 0.93
HLA-A29 and birdshot chorioretinopathy. Ocul Immunol Inflamm (2011) 0.93
HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease. Tissue Antigens (2001) 0.91
Cytokine polymorphism in noninfectious uveitis. Invest Ophthalmol Vis Sci (2010) 0.90
Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis (2008) 0.89
Serum interleukin 2-receptor levels in uveitis. Curr Eye Res (1990) 0.87
Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU). Mol Vis (2009) 0.86
Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing. Jpn J Ophthalmol (2008) 0.86
Chemokine gene polymorphisms in idiopathic anterior uveitis. Cytokine (2006) 0.84
Genetics in uveitis. Int Ophthalmol Clin (2005) 0.83
CFH 184G as a genetic risk marker for anterior uveitis in Chinese females. Mol Vis (2011) 0.83
Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease. Hum Immunol (1999) 0.83
Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis. Curr Eye Res (2002) 0.82
Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses. J Biol Chem (2011) 0.81
[Effects of interleukin-2 on experimental uveitis and pinealitis]. Zhonghua Yan Ke Za Zhi (1993) 0.78
HLA antigens in uveitis. Hum Immunol (1983) 0.78
Physical map of human 6p21.2-6p21.3: region flanking the centromeric end of the major histocompatibility complex. Genome Res (1998) 0.77
Complement factor B expression profile in a spontaneous uveitis model. Immunobiology (2010) 0.76
Wide-field spectral domain-optical coherence tomography in central serous chorioretinopathy. Int Ophthalmol (2015) 0.89
The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res (2017) 0.75